# Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi

> **NCT03926780** · PHASE3 · COMPLETED · sponsor: **The Young Investigator Group of Cardiovascular Research** · enrollment: 79 (actual)

## Conditions studied

- Anticoagulants; Increased
- Left Ventricular Thrombosis

## Interventions

- **DRUG:** Rivaroxaban 20 MG
- **DRUG:** Warfarin Sodium

## Key facts

- **NCT ID:** NCT03926780
- **Lead sponsor:** The Young Investigator Group of Cardiovascular Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03926780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03926780, "Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03926780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*